Irish v. Janssen Pharmaceuticals Inc et al
Margaret Irish |
Janssen Pharmaceuticals Inc, Johnson & Johnson, Teva Branded Pharmaceutical Products R&D Inc, Teva Pharmaceuticals USA, Inc., Johnson & Johnson Inc, Teva Branded Pharmaceutical Products R&D and Teva Pharmaceuticals USA Inc |
3:2022cv05073 |
February 3, 2022 |
US District Court for the Western District of Washington |
David G Estudillo |
Personal Inj. Prod. Liability |
28 U.S.C. ยง 1446 pl Petition for Removal - Product Liability |
None |
Docket Report
This docket was last retrieved on February 16, 2022. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 10 TRANSFERRED CASE opened in District of New Jersey as case 2:22-cv-00843 on 2/16/2022. (LH) |
Filing 9 MDL 2973 CONDITIONAL TRANSFER ORDER (CTO 25); in re Elmiron (Pentosan Polysulfate Sodium) Products Liability Litigation; transferred to the District of New Jersey; assigned to Judge Brian R. Matinotti. (Attachments: #1 CTO transfer letter, #2 CTO transfer email)(LH) |
Filing 8 CORRECTED Notice of Filing Deficiency re #4 Case/IFP Deficiency Letter, #1 Notice of Removal,. ***Action Required*** Attorney Admission.See attached letter for more information and instructions. (CDA)ad hoc Attorney Nichols |
Case transferred to the District of New Jersey by electronic case transfer on 2/15/2022. (LH) |
Filing 7 ORDER granting #6 Stipulated MOTION for Extension of Time to File Responsive Pleading to Complaint signed by U.S. District Judge David G. Estudillo. Defendants shall answer or otherwise respond to the Complaint by February 24, 2022. (ZMG) |
Filing 6 Stipulated MOTION for Extension of Time to File Responsive Pleading to Complaint, and [Proposed] Order, filed by Defendants Janssen Pharmaceuticals Inc, Johnson & Johnson Inc. (Attachments: #1 Exhibit Exhibit A)(Clark, Matthew) |
Filing 5 LETTER from Clerk to re receipt of case from Clark County Superior Court and advising of WAWD case number and judge assignment. (GMR- ad hoc atty C. Nichols) |
Filing 4 Notice of Filing Deficiency re #1 Notice of Removal. ***Action Required*** -Pro Hac Vice Admission required for attorney Thomas G McIntosh (no further notice will be sent), -ECF Filing Mandatory for attorney Craig Nichols. See attached letter for more information and instructions. (GMR- ad hoc atty C. Nichols) |
U.S. District Judge David G. Estudillo added. (ZMG) |
Filing 3 NOTICE to Adverse Party of Removal re #1 Notice of Removal, ; filed by Defendants Janssen Pharmaceuticals Inc, Johnson & Johnson. (Clark, Matthew) |
Filing 2 CORPORATE DISCLOSURE STATEMENT indicating no Corporate Parents and/or Affiliates. Filed pursuant to Fed.R.Civ.P 7.1. Filed by Janssen Pharmaceuticals Inc, Johnson & Johnson (Clark, Matthew) |
Filing 1 NOTICE OF REMOVAL from Clark County Superior Court, case number 22-2-00055-06; (Receipt # AWAWDC-7426507), filed by Janssen Pharmaceuticals Inc, Johnson & Johnson. (Attachments: #1 Exhibit A - Complaint, #2 Exhibit B - Consent, #3 Civil Cover Sheet, #4 Supplement Additional State Court Records and Pleadings)(Clark, Matthew) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Washington Western District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.